- A study from Brown University found that primary care visits increased by 18% after private equity acquisition, challenging the belief that investor ownership degrades healthcare.
- Private equity-backed clinics expanded their provider workforce by 23%, saw longer operating hours, and reduced patient wait times.
- Researchers tracked over 300 primary care practices across 12 states from 2016 to 2023 to collect their findings.
- The study suggests that capital infusion from private equity may enhance the capacity of overburdened primary care systems in some cases.
- The findings highlight the complexity of integrating market forces into healthcare delivery, offering a nuanced picture of private equity’s impact.
Primary care visits increased by 18% in the first two years after private equity acquisition, according to a landmark study from Brown University’s School of Public Health—challenging the widely held belief that investor ownership degrades healthcare quality and access. Tracking over 300 primary care practices across 12 states from 2016 to 2023, researchers found that clinics backed by private equity firms not only expanded their provider workforce by an average of 23% but also saw longer operating hours and reduced patient wait times. While concerns about cost inflation and profit extraction remain, the data suggest that capital infusion from private equity may, in some cases, enhance the capacity of overburdened primary care systems. This nuanced picture underscores the complexity of integrating market forces into foundational healthcare delivery.
Why This Matters Now
The U.S. faces a growing primary care shortage, with the Association of American Medical Colleges projecting a deficit of up to 48,000 primary care physicians by 2034. At the same time, private equity investment in healthcare has surged, exceeding $170 billion since 2010, according to data from the American Hospital Association. Primary care—a traditionally low-margin, high-volume sector—has increasingly attracted investor interest due to its potential for operational streamlining and consolidation. The Brown study arrives amid intensified scrutiny from policymakers and medical associations, many of whom warn that profit-driven models could erode patient trust and clinical autonomy. However, the observed expansion in access and staffing suggests that, under certain conditions, private equity may play a constructive role in scaling care delivery, especially in underserved regions where traditional models struggle to sustain operations.
What the Study Found
Researchers analyzed electronic health record data, staffing records, and patient utilization patterns from 312 primary care clinics, 156 of which were acquired by private equity firms during the study period and 156 serving as matched controls. Acquired clinics were primarily located in suburban and rural areas, with a median patient panel of 3,200. Within 24 months post-acquisition, these practices increased their number of primary care providers—physicians, nurse practitioners, and physician assistants—by 23%, compared to a 6% rise in control clinics. Patient visit volume rose by 18%, and clinics extended evening and weekend hours in 68% of cases. The study, published in Health Affairs, controlled for regional market factors, pre-acquisition performance, and payer mix. Notably, the research team found no significant increase in high-cost referrals or unnecessary testing, which are often cited as risks of investor-owned care.
Drivers Behind the Expansion
The growth in access appears tied to strategic reinvestment of capital, particularly in staffing and infrastructure. Private equity firms often deploy capital to hire mid-level providers, adopt electronic scheduling systems, and open satellite locations—tactics aimed at increasing throughput and patient retention. Dr. Rachel Kim, lead author and health policy professor at Brown, noted, “These firms are not just cutting costs—they’re scaling operations in ways that traditional solo or small group practices can’t match.” The study also found that acquired practices were more likely to integrate behavioral health services and chronic disease management programs, suggesting a shift toward value-based care models. However, the researchers caution that long-term outcomes, including clinician burnout and patient satisfaction, remain understudied. Prior research from BBC News investigations has documented cases where initial improvements gave way to cost-cutting pressures and staff turnover, highlighting the dual-edged nature of private equity involvement.
Who Benefits—and Who Might Lose
Patients in medically underserved areas appear to benefit most from expanded access, particularly those with chronic conditions requiring regular follow-up. The influx of providers and extended hours can reduce barriers to care, especially for working families. However, concerns persist about long-term sustainability and equity. Some physician groups argue that private equity’s focus on scalability may prioritize volume over personalized care, potentially undermining the doctor-patient relationship. Additionally, while staffing increased overall, the proportion of non-physician providers grew faster, raising questions about scope of practice and care continuity. Financial risks also remain: private equity firms typically exit investments within 5–7 years, often through resale or public offering, which could destabilize clinics if successor owners pursue different strategies. Patients and providers alike may face disruption when ownership changes hands a second time.
Expert Perspectives
Health economists are divided on the implications. Dr. Amit Patel of the University of California, San Francisco, views the findings cautiously: “Increased access is welcome, but we must watch for downstream effects on care quality and workforce morale.” In contrast, Dr. Linda Chen of the Brookings Institution argues that private equity fills a critical funding gap: “If traditional financing won’t support clinic expansion, we need to consider alternative models—even imperfect ones.” Medical associations like the American Academy of Family Physicians remain skeptical, warning that profit motives may eventually compromise clinical judgment. The debate underscores a broader tension in U.S. healthcare: how to expand access without commodifying care.
Going forward, researchers urge greater transparency in private equity healthcare deals and stronger regulatory oversight to ensure patient interests are protected. Key questions remain: Do these gains persist beyond the initial investment phase? How do outcomes vary by firm, region, or practice size? As private equity continues to reshape primary care, policymakers, providers, and patients must navigate a rapidly evolving landscape where access and accountability must grow in tandem.
Source: MedicalXpress